Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Halia Therapeutics Inc.
Headquarters: Lehi, UT, United States of America
Website: https://www.haliatherapeuti...
Year Founded: 2017
Status: Private
BioCentury | Jan 11, 2025
Management Tracks
Faces in new places ahead of JPM: Rubin joining Guggenheim
Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
BioCentury | Jan 7, 2025
Management Tracks
John Finn named CSO of Basecamp
Plus: Iambic hires Michael Secora and updates from Septerna, Beigene, Perspective, Halia and more
BioCentury | May 23, 2024
Emerging Company Profile
Halia: Leveraging RAB10 as a new lens on the NLRP3 inflammasome
Guided by human variation in the GTPase RAB10, Utah-based company seeks to disrupt inflammasome assembly
BioCentury | Feb 2, 2024
Finance
VC roundup: New funds for TCG and Seroba, rounds for Cour and Aqemia
Plus fresh cash for Halia and Neophore, and a new spinout from venture-backed Cumulus Oncology
BioCentury | Jan 20, 2023
Management Tracks
Radcliffe becomes new CFO at Cardurion
Plus: Granaturova becomes COO and CBO at Normunity, and updates from
BioCentury | Dec 16, 2022
Data Byte
NLRP3 clinical progress
New data from EpicentRx boost confidence in NLRP3 as a cancer target, with a pair of autoimmune programs not far behind
Items per page:
1 - 6 of 6